The rise of GLP-1 medications for rapid and significant weight loss has sparked considerable interest in the healthcare community. Given the drug’s effects on managing type 2 diabetes, it is no surprise that DexCom’s CEO, Jake Leach, aims to capitalize on this trend. DexCom manufactures continuous glucose monitoring (CGM) devices that patients wear around the clock, originally designed for type 1 diabetics needing precise insulin management. However, as evidence of CGM effectiveness grows, these devices are increasingly prescribed to type 2 diabetes patients as well.<\/p>\n
“We are working on utilizing CGMs to optimize pharmacological therapies, starting with insulin, but there are also opportunities with GLP-1,” Leach remarked in a recent interview. “We have various opportunities to guide therapy so that doctors and patients can collaborate for better outcomes more quickly.”<\/p>\n
CGMs provide diabetics with real-time glucose levels by measuring glucose in the interstitial fluid surrounding cells. Traditional blood tests yield A1c results that are more reliable but require frequent blood draws, which can be burdensome. CGMs, prescribed by healthcare providers, feature a small sensor inserted under the skin that delivers continuous glucose data throughout the day.<\/p>\n
Both obesity and type 2 diabetes are metabolic disorders, with GLP-1 medications effectively acting as appetite suppressants, influencing metabolic rates and insulin levels.<\/p>\n
“GLP-1s yield excellent results. However, I believe, and the data we review supports, that using CGMs in conjunction with GLP-1s results in better outcomes primarily because they target different aspects,” Leach stated. “CGMs help individuals understand how various foods, activity levels, and choices affect their glucose, while GLP-1s reveal improvements in well-being attributed to the medication.”<\/p>\n
If one relies solely on GLP-1s without monitoring blood glucose, “the only real feedback on health is weight, which may take up to 90 days to reflect in A1c levels,” Leach added.<\/p>\n
Furthermore, CGMs assist patients in tailoring their diets. “Some crucial insights into good nutrition come not from GLP-1s but from CGMs,” he noted, although he acknowledged a lack of data on the extent of GLP-1 use among type 2 diabetic patients.<\/p>\n
Leach also pointed out the financial viability of using CGMs alongside GLP-1s for individuals managing type 2 diabetes. “I believe CGMs are a highly cost-effective solution. The annual cost of using a CGM is about $1,000, making a compelling financial argument when comparing potential healthcare savings.”<\/p>\n
Indeed, a study assessing the cost-effectiveness of CGMs for patients on GLP-1s supports Leach\u2019s perspective. Conducted by a consulting physician from Abbott, a competing company that produces its own CGM product, the FreeStyle Libre, the study highlights the ongoing market competition. Although Abbott’s technology functions differently from DexCom’s, it has gained market share over time. (Note: As of 2022, Abbott\u2019s CGM technology no longer requires manual sensor scanning for each reading, while DexCom provides updates every five minutes, according to the company’s website.)<\/p>\n
In response to market dynamics and to strengthen its position as a leading innovator in CGM technology, DexCom plans to unveil the DexCom G8 sensor. This upcoming product is expected to be the smallest CGM ever upon its release.<\/p>\n
“This will be the most advanced portable system we have ever produced,” Leach stated during the January 12 conference. “Design modifications will ensure improved detection and error management. The new sensor will also be 50% smaller than the G7 model, making it the smallest CGM available on the market.” No specific launch date has yet been announced.<\/p>\n
As DexCom navigates its strategy\u2014whether through international sales expansion, aligning with the GLP-1 wave, or launching a smaller and more advanced CGM device\u2014the company\u2019s stock could benefit from a positive turnaround. After peaking above $160 in November 2021, DexCom’s stock has since lost nearly half its value, impacted by various setbacks, including a mismanaged sales restructure and a warning letter from the FDA regarding the conditions of two manufacturing facilities.<\/p>\n
Currently, the stock trades near $70, with investors eyeing the upcoming earnings report on February 12 for the fourth quarter and fiscal year 2025.<\/p>\n","protected":false},"excerpt":{"rendered":"
The rise of GLP-1 medications for rapid and significant weight loss has sparked considerable interest…<\/p>\n","protected":false},"author":1,"featured_media":1662,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[20],"tags":[],"class_list":["post-1661","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diagnostic"],"_links":{"self":[{"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/posts\/1661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/comments?post=1661"}],"version-history":[{"count":1,"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/posts\/1661\/revisions"}],"predecessor-version":[{"id":1663,"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/posts\/1661\/revisions\/1663"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/media\/1662"}],"wp:attachment":[{"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/media?parent=1661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/categories?post=1661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/naturalhealthcontent.com\/index.php\/wp-json\/wp\/v2\/tags?post=1661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}